EMA Authorised: Fuzeon (enfuvirtide) — Roche Registration GmbH

View source ↗

Summary

A European Medicines Agency page indicates that Fuzeon (enfuvirtide) by Roche Registration GmbH is authorised for HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Fuzeon (enfuvirtide)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Roche Registration GmbH. Decision date: 16/10/2023